rs3783408
Variant names:
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The ENST00000441560.6(ATL1):c.-140+108C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.202 in 152,032 control chromosomes in the GnomAD database, including 3,868 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.20 ( 3868 hom., cov: 32)
Exomes 𝑓: 0.17 ( 0 hom. )
Failed GnomAD Quality Control
Consequence
ATL1
ENST00000441560.6 intron
ENST00000441560.6 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.0290
Publications
9 publications found
Genes affected
ATL1 (HGNC:11231): (atlastin GTPase 1) The protein encoded by this gene is a GTPase and a Golgi body transmembrane protein. The encoded protein can form a homotetramer and has been shown to interact with spastin and with mitogen-activated protein kinase kinase kinase kinase 4. This protein may be involved in axonal maintenance as evidenced by the fact that defects in this gene are a cause of spastic paraplegia type 3. Three transcript variants encoding two different isoforms have been found for this gene. [provided by RefSeq, Jul 2008]
MAP4K5 (HGNC:6867): (mitogen-activated protein kinase kinase kinase kinase 5) This gene encodes a member of the serine/threonine protein kinase family, that is highly similar to yeast SPS1/STE20 kinase. Yeast SPS1/STE20 functions near the beginning of the MAP kinase signal cascades that is essential for yeast pheromone response. This kinase was shown to activate Jun kinase in mammalian cells, which suggested a role in stress response. Two alternatively spliced transcript variants encoding the same protein have been described for this gene. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.82).
BP6
Variant 14-50533475-C-T is Benign according to our data. Variant chr14-50533475-C-T is described in ClinVar as Benign. ClinVar VariationId is 1262528.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.276 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| ATL1 | NM_001127713.1 | c.-140+108C>T | intron_variant | Intron 1 of 13 | NP_001121185.1 | |||
| MAP4K5 | XM_047430893.1 | c.-109-1317G>A | intron_variant | Intron 2 of 33 | XP_047286849.1 | |||
| MAP4K5 | XM_047430897.1 | c.-109-1317G>A | intron_variant | Intron 2 of 32 | XP_047286853.1 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| ATL1 | ENST00000441560.6 | c.-140+108C>T | intron_variant | Intron 1 of 13 | 1 | ENSP00000413675.2 | ||||
| ATL1 | ENST00000556478.3 | c.-140+602C>T | intron_variant | Intron 1 of 13 | 2 | ENSP00000501428.2 | ||||
| ATL1 | ENST00000713928.1 | c.-140+529C>T | intron_variant | Intron 1 of 13 | ENSP00000519225.1 |
Frequencies
GnomAD3 genomes AF: 0.202 AC: 30693AN: 151914Hom.: 3868 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
30693
AN:
151914
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome Data not reliable, filtered out with message: AS_VQSR AF: 0.167 AC: 1AN: 6Hom.: 0 AF XY: 0.167 AC XY: 1AN XY: 6 show subpopulations
GnomAD4 exome
Data not reliable, filtered out with message: AS_VQSR
AF:
AC:
1
AN:
6
Hom.:
AF XY:
AC XY:
1
AN XY:
6
show subpopulations
African (AFR)
AC:
0
AN:
0
American (AMR)
AC:
0
AN:
0
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
2
East Asian (EAS)
AF:
AC:
1
AN:
2
South Asian (SAS)
AC:
0
AN:
0
European-Finnish (FIN)
AC:
0
AN:
0
Middle Eastern (MID)
AC:
0
AN:
0
European-Non Finnish (NFE)
AF:
AC:
0
AN:
2
Other (OTH)
AC:
0
AN:
0
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.575
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
GnomAD4 genome AF: 0.202 AC: 30700AN: 152032Hom.: 3868 Cov.: 32 AF XY: 0.201 AC XY: 14907AN XY: 74280 show subpopulations
GnomAD4 genome
AF:
AC:
30700
AN:
152032
Hom.:
Cov.:
32
AF XY:
AC XY:
14907
AN XY:
74280
show subpopulations
African (AFR)
AF:
AC:
2331
AN:
41486
American (AMR)
AF:
AC:
3050
AN:
15278
Ashkenazi Jewish (ASJ)
AF:
AC:
812
AN:
3470
East Asian (EAS)
AF:
AC:
909
AN:
5166
South Asian (SAS)
AF:
AC:
1176
AN:
4818
European-Finnish (FIN)
AF:
AC:
2675
AN:
10546
Middle Eastern (MID)
AF:
AC:
84
AN:
294
European-Non Finnish (NFE)
AF:
AC:
18974
AN:
67950
Other (OTH)
AF:
AC:
488
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
1212
2423
3635
4846
6058
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
332
664
996
1328
1660
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
598
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Jun 23, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.